← FDA DRUG APPROVALS

FDA ANDA · ANDA074974

LORAZEPAM

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA074974
TYPE
ANDA
ORIGINAL APPROVAL
1998-07-23
LATEST ACTION
2001-03-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LORAZEPAMDiscontinued
LORAZEPAM 2MG/ML · INJECTABLE · INJECTION

Approval history

2001-03-05Manufacturing (CMC) · Supplement 2AP
2000-04-28Manufacturing (CMC) · Supplement 3AP
1999-06-07Manufacturing (CMC) · Supplement 1AP
1998-07-23OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →